These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15637648)

  • 41. Primary central nervous system lymphoma.
    Stern JI; Raizer JJ
    Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S63-70. PubMed ID: 16274272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
    Grossman SA; Finkelstein DM; Ruckdeschel JC; Trump DL; Moynihan T; Ettinger DS
    J Clin Oncol; 1993 Mar; 11(3):561-9. PubMed ID: 8445432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis.
    Chamberlain MC; Tsao-Wei DD; Groshen S
    Cancer; 2006 May; 106(9):2021-7. PubMed ID: 16583432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of neoplastic meningitis: what is the standard of care?
    Recht L; Phuphanich S
    Expert Rev Neurother; 2004 Jul; 4(4 Suppl):S11-7. PubMed ID: 15853550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary CNS lymphoma: is there a role for prophylaxis against lymphomatous meningitis?
    DeAngelis L; Batchelor T
    Expert Rev Neurother; 2004 Jul; 4(4 Suppl):S19-24. PubMed ID: 15853551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple myeloma of the central nervous system: a clinicopathological review.
    Al-Sobhi E; Osoba AO; Karar A; Zuraiki AM
    East Mediterr Health J; 2009; 15(6):1570-9. PubMed ID: 20218151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Yamanaka R; Morii K; Shinbo Y; Takeuchi S; Tamura T; Hondoh H; Takahashi H; Onda K; Takahashi H; Tanaka R
    Ann Hematol; 2005 Jul; 84(7):447-55. PubMed ID: 15747120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
    Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment modalities for leptomeningeal metastases.
    Shapiro WR; Johanson CE; Boogerd W
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S46-54. PubMed ID: 19660683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoplastic meningitis.
    Van Horn A; Chamberlain MC
    J Support Oncol; 2012; 10(2):45-53. PubMed ID: 22005214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary central nervous system lymphoma.
    DeAngelis LM
    Recent Results Cancer Res; 1994; 135():155-69. PubMed ID: 8047690
    [No Abstract]   [Full Text] [Related]  

  • 52. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
    Cagayan MS; Lu-Lasala LR
    J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuro-oncology.
    Hildebrand J
    Acta Neurol Belg; 1996 Sep; 96(3):232-7. PubMed ID: 8886110
    [No Abstract]   [Full Text] [Related]  

  • 55. Pediatric central nervous system germ cell tumors: a review.
    Echevarría ME; Fangusaro J; Goldman S
    Oncologist; 2008 Jun; 13(6):690-9. PubMed ID: 18586924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy in neoplastic meningitis.
    Pace A; Fabi A
    Crit Rev Oncol Hematol; 2006 Dec; 60(3):194-200. PubMed ID: 16949298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
    Shenkier TN; Voss N; Chhanabhai M; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Morris J; O'Reilly SE; Pickles T; Sehn L; Connors JM
    Cancer; 2005 Mar; 103(5):1008-17. PubMed ID: 15651059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Meningeal carcinomatosis].
    Sulim S; Høyer M
    Ugeskr Laeger; 2005 Sep; 167(37):3481-4. PubMed ID: 16159454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
    Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.